Press Releases

TrialScope Adds Eisai to Its Community of Study Sponsors

TrialScope, the global leader in clinical trial disclosure and transparency management technology, has added Eisai to its growing customer roster.

New Zealand’s Ubiquitome signs NIH RADx contract

Ubiquitome, the only company outside the US, has received NIH RADx funds to develop its open RT-PCR the Liberty16 to test for COVID-19 in US hospitals and mobile labs

Indica Labs announces launch of enterprise-wide, cloud-based digital pathology deployment at NCI

Indica Labs announced today the launch of an enterprise-wide, cloud-based deployment of the HALO®, HALO AI, HALO Link and HALO AP software within the National Cancer Institute (NCI) – which I thought would be of interest to you and your readers. The existing on-premise HALO licenses at the NCI are siloed and only accessible to specific research groups. The new deployment has been designed to expand accessibility to hundreds of users within the NCI, managing millions of digital images and facilitating the analysis of thousands of images daily. Taking a cloud-based approach, the deployment also simplifies data sharing and enables real-time collaboration between the NCI and both internal and external researchers in ways that were not previously possible.

Noxopharm Announces First COVID-19 Patient Treated in Veyonda® Study

Noxopharm is pleased to announce treatment of the first patient with its lead pipeline candidate, Veyonda®, in the Company’s Phase 1 NOXCOVID-1 study.

Alfa Chemistry Materials Offers Wide Options of Resins for Decoration or Manufacture of Plastics

AI & Medicine’s Drug Research and Development Platform Assists Biomarker Discovery

CD Genomics Optimized NGS Oncology Panels for Cancer Related Research

Study Shows Proof of Concept of BioIVT HEPATOPAC Cultures with Targeted Assay to Evaluate Bioactivation Potential and Drug-induced Liver Injury (DILI) Risk

New in vitro Bioactivation Liver Response Assay used HEPATOPAC model to demonstrate utility of in vitro transcriptomic signature-based strategy in preclinical DILI risk assessment 

Cytel ushers in new era of optimized clinical trial design with launch of Solara™

Cytel is set to revolutionize clinical trial design planning with the launch of SolaraTM, a collaborative decision-support platform for greater development productivity and better business results. Overcoming a critical bottleneck in pharma & biotech The platform will fundamentally reimagine clinical trial design – a process renowned for its tight design timelines and the convoluted process of reaching stakeholder consensus on the most suitable trial design. The only platform of its kind The platform applies massive cloud computing power to rapidly explore an exponentially larger design space than is possible using traditional design methods. It is the only platform to integrate statistical and business considerations into the trial design process and includes intuitive visualization tools to optimize decision-making.

BioIVT Launches HEPATOMUNE Kit to Facilitate Liver Toxicity and Inflammation Studies for Drug Discovery and Disease Research

Applications for this model include assessing drug candidates’ hepatotoxicity, and studying inflammation-related diseases 

ATMPS advanced therapy blockchain platform has successful testing with NHS partners

New ‘blockchain ecosystem’ has potential to track, from vein-to-vein, advanced therapies

Alfa Chemistry Testing Lab Builds an Exclusive Regulatory Resource Section on Its Website

SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology

SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology.

Sakura Finetek Europe launches Tissue-Tek SmartConnect®, a new chapter in automation and the next step for laboratories in achieving future-proof pathology.

https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-tissue-tek-smartconnect

Ben-Gurion University Researcher Develops and Licenses New Clinical Trials Platform Based on Machine Learning

The new platform leverages machine learning to optimize a clinical trial’s chances of success, by analyzing patient population recruitment and dropout rate, as well as identifying and prioritizing monitored markers. It provides efficient pre-trial recommendations, in-trial interim analysis, and post-trial insights for next trial preparation, as well as potential salvage options in case of failure.

Aurinia Pharmaceuticals selects MyMeds&Me’s Reportum QuickStart platform to streamline drug safety reporting

MyMeds&Me, a leading provider of drug safety software to transform the end-to-end pharmacovigilance process, have today announced that Aurinia Pharmaceuticals Inc. has selected the Reportum QuickStart platform to streamline the capture, processing and management of safety data for the investigational drug voclosporin, following recent positive Phase 3 results.

Atik Cameras Develops New Products for Use with qPCR Instruments for Accurate, Reliable COVID-19 Testing

Atik Cameras today announced the launch of the VS255 and VS825 cameras for use specifically with quantitative Polymerase Chain Reaction (qPCR) instruments for accurate, reliable COVID-19 Testing – which I thought would be of interest to you and your readers. The qPCR test is vital in pinpointing COVID-19 positive cases and the timeframes in which these cases pose the greatest risk of spreading the SARS-CoV-2 virus to the wider population. With the paramount importance of the COVID-19 challenge, it was vital that Atik Cameras provided products that were well suited to the task. The commercially-competitive, custom VS255 and VS825 cameras offer superior sensitivity and image quality enabling Original Equipment Manufacturers (OEMs) and clinical diagnostic laboratories to achieve accurate diagnosis of active COVID-19 infections.

Dublin-based start-up launch Wirano – a global digital platform for organizing clinical trials

A Dublin-based tech start-up today announced the launch of Wirano – a digital platform for the rapid and effective organization of clinical trials – which I thought would be of interest to you and your readers. The success rate of clinical trials is just 14%, with patient recruitment being a key hurdle. Wirano aims to improve this rate by optimizing the patient recruitment process, improving site and investigator selection procedures, and creating reliable channels for effective communication between all participants.

BOC Sciences Lanuched A New Biotinylation Platform

Global Genes and Rady Children’s Institute for Genomic Medicine Partner to Develop Next-Generation Support Network for Families with Diagnosed Gene-Based Rare Diseases

Global Genes, a leading rare disease patient advocacy organization, is pleased to announce a new partnership with Rady Children’s Institute for Genomic Medicine (RCIGM) to develop a next-generation support network for families with gene-based diagnosed rare diseases.